Filing Details

Accession Number:
0001144204-15-051169
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-21 09:00:28
Reporting Period:
2015-08-20
Filing Date:
2015-08-21
Accepted Time:
2015-08-21 09:00:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1137883 Brainstorm Cell Therapeutics Inc. BCLI Biological Products, (No Disgnostic Substances) (2836) 207273918
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1576822 Yoram Bibring C/O Brainstorm Cell Therapeutics Inc.
3 University Plaza Drive, Suite 320
Hackensack NJ 07601
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-20 8,500 $3.04 50,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.00 to $3.0455, inclusive. The reporting person undertakes to provide to Brainstorm Cell Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.